(Q30394816)

21 June 2017

Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease (English)

1 reference

21 June 2017

1 reference

1 reference

1

D Allan Butterfield

1 reference

21 June 2017

Tanea Reed

2

1 reference

PubMed ID

20942567

21 June 2017

Rukhsana Sultana

series ordinal

3

1 reference

21 June 2017

13 October 2010

1 reference

21 June 2017

Free Radical Research

1 reference

21 June 2017

45

1 reference

21 June 2017

1

1 reference

21 June 2017

59-72

1 reference

The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism

21 June 2017

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Oxidative stress hypothesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Mild cognitive impairment as a clinical entity and treatment target

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Chemistry, physiology and pathology of free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Nitrosation, nitration, and autoxidation of the selective estrogen receptor modulator raloxifene by nitric oxide, peroxynitrite, and reactive nitrogen/oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

S-nitrosylation of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Peroxynitrite-dependent tyrosine nitration catalyzed by superoxide dismutase, myeloperoxidase, and horseradish peroxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Proteomic identification of nitrated proteins in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Dynamics of protein nitration in cells and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superox

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Nitric oxide, cell bioenergetics and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Nitration of tau protein is linked to neurodegeneration in tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Focused proteomics in post-mortem human spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

A proteomic approach in the study of an animal model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Increased protein oxidation and decreased creatine kinase BB expression and activity after spinal cord contusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Neurochemical enzyme changes in Alzheimer's and Pick's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Triosephosphate isomerase deficiency: haemolytic anaemia, myopathy with altered mitochondria and mental retardation due to a new variant with accelerated enzyme catabolism and diminished specific activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Human aldolase A deficiency associated with a hemolytic anemia: thermolabile aldolase due to a single base mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Memory function and brain glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

The heme oxygenase/biliverdin reductase pathway in drug research and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Neuron numbers and dendritic extent in normal aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Catalases and thioredoxin peroxidase protect Saccharomyces cerevisiae against Ca(2+)-induced mitochondrial membrane permeabilization and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Proteome analysis of human substantia nigra in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Peroxynitrite reductase activity of bacterial peroxiredoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Oxidation of active center cysteine of bovine 1-Cys peroxiredoxin to the cysteine sulfenic acid form by peroxide and peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase pi with activity changes in both enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Increased CSF F2-isoprostane concentration in probable AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Oxidative and nitrosative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Biomarkers of oxidative damage and inflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Carbonyl toxicology and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Evidence of increased oxidative damage in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Gluconeogenesis in the kidney in vivo in fed rats. Circadian change and substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Increased oxidation of certain glycolysis and energy metabolism enzymes in the frontal cortex in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Protein carbonyl formation in the diaphragm

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Mitochondrial dysfunction and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease--therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Mitochondria and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Oxidative imbalance in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Oxidative stress and neurodegeneration: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Mitochondrial abnormalities in Alzheimer brain: mechanistic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Synaptic and neuritic alterations during the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Cytoskeletal modifications induced by 4-hydroxynonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Human carbonyl reductase (CBR) localized to band 21q22.1 by high-resolution fluorescence in situ hybridization displays gene dosage effects in trisomy 21 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Alzheimer's disease and down syndrome: from meiosis to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

The human mitochondrial elongation factor tu (EF-Tu) gene: cDNA sequence, genomic localization, genomic structure, and identification of a pseudogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Participation of the mitochondrial genome in the differentiation of neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

The structure and function of initiation factors in eukaryotic protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Ribosome dysfunction is an early event in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

NMDA receptor activation enhances the release of a cholinergic differentiation peptide (HCNP) from hippocampal neurons in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Alteration of NMDA receptor-mediated synaptic responses in CA1 area of the aged rat hippocampus: contribution of GABAergic and cholinergic deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Cholinergic deficit in frontal cerebral cortex in Alzheimer's disease is age dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

The cholinergic hypothesis of Alzheimer's disease: a review of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Function of myosin-V in filopodial extension of neuronal growth cones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Dendritic and spinal pathology in the acoustic cortex in Alzheimer's disease: morphological and morphometric estimation by Golgi technique and electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Role of protein oxidation in aging and in age-associated neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Oxidative stress: free radical production in neural degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

A Novel Reaction Mechanism for the Formation ofS-Nitrosothiolin Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

Actin Cys374 as a nucleophilic target of α,β-unsaturated aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.520014

10.3109/10715762.2010.520014

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference

PubMed ID

20942567